I am a research technician Serrano Lab since 2022. I am a cell biologist specialized in biochemistry, immunology with strong focus on cancer biology and more than 10 years’ experience. I am working as a part of the collaboration agreement with Orikine.

Background

2022-present: Lab technician at the Centre for Genomic Regulation, Systems and Synthetic Biology Program.

2016-2021: Post Doc at  Bellvitge Biomedical Research Institute (IDIBELL)

2010-2015: PhD in Biomedicine at Barcelona University (UB)

2009-2010: Masters degree in Biomedical Investigation at UPF

Publications

Sánchez-Morales A; Biçer A; Panagiotopoulos V; Crecente-Garcia S; Benaiges C; Bayod S; Luís Hernández J; Busqué F; Matsoukas MT; Pérez-Riba M; Alibés R, 2022. Design and synthesis of a novel non peptide CN-NFATc signaling inhibitor for tumor suppression in triple negative breast cancer.  Eur J Med Chem 238:114514

Biçer A; López-Henares P; Molero-Magariño M; Feu-Llauradó A; Sabariego-Navarro M; Bayod S; Padilla L; Taco MR; Larriba S; Pérez-Riba M; Serrano-Candelas E, 2022. The PxIxIT motif of the RCAN3 inhibits angiogenesis and tumor progression in Triple Negative breast cancer in immunocompetent mice.  Carcinogenesis 43(8):808-812

Teixeira JMC; Guasch A; Biçer A; Aranguren-Ibáñez Á; Chashmniam S; Paniagua JC; Pérez-Riba M; Fita I; Pons M, 2019. Cis-trans proline isomers in the catalytic domain of calcineurin.  FEBS J 286(6):1230-1239

Biçer A; Orlando S; Islam ABMMK; Gallastegui E; Besson A; Aligué R; Bachs O; Pujol MJ, 2017. ChIP-Seq analysis identifies p27(Kip1)-target genes involved in cell adhesion and cell signalling in mouse embryonic fibroblasts.  PLoS One 12(11):e0187891

Ozkan A; Biçer A; Avşar T; Seker A; Toktaş ZO; Bozkurt SU; Başak AN; Kılıç T, 2012. Temporal expression analysis of angiogenesis-related genes in brain development.  Vasc Cell 4(1):16

Yildirim O; Bicer A; Ozkan A; Kurtkaya O; Cirakoglu B; Kilic T, 2010. Expression of platelet-derived growth factor ligand and receptor in cerebral arteriovenous and cavernous malformations.  J Clin Neurosci 17(12):1557-62

Sun HI; Akgun E; Bicer A; Ozkan A; Bozkurt SU; Kurtkaya O; Koc DY; Pamir MN; Kilic T, 2010. Expression of angiogenic factors in craniopharyngiomas: implications for tumor recurrence.  Neurosurgery 66(4):744-50; discussion 750

Toktas ZO; Bicer A; Demirci G; Pazarli H; Abacioglu U; Peker S; Kilic T, 2010. Gamma knife stereotactic radiosurgery yields good long-term outcomes for low-volume uveal melanomas without intraocular complications.  J Clin Neurosci 17(4):441-5

Bicer A; Guclu B; Ozkan A; Kurtkaya O; Koc DY; Necmettin Pamir M; Kilic T, 2010. Expressions of angiogenesis associated matrix metalloproteinases and extracellular matrix proteins in cerebral vascular malformations.  J Clin Neurosci 17(2):232-6

Genç A; Bicer A; Abacioglu U; Peker S; Pamir MN; Kilic T, 2010. Gamma knife radiosurgery for the treatment of glomus jugulare tumors.  J Neurooncol 97(1):101-8

Eskiocak U; Işeri OD; Kars MD; Biçer A; Gunduz U, 2008. Effect of doxorubicin on telomerase activity and apoptotic gene expression in doxorubicin-resistant and -sensitive MCF-7 cells: an experimental study.  Chemotherapy 54(3):209-16

Publication list retrieved from NCBI using ImpactPubs